乳腺活检标记物超声彩色多普勒闪烁伪像的相关因素:35种市售标记物体外与离体评估
该研究评估35种市售乳腺活检标记物在凝胶体模、耦合剂和尸体乳腺中的闪烁伪像,发现嵌入材料存在和探头类型与闪烁评分相关,C1-6和9L探头比ML6-15更易观察到可信闪烁,且可操作闪烁与标记物表面粗糙度更高相关。
要点
- 使用C1-6或9L探头比ML6-15探头更易观察到标记物的可操作闪烁伪像。
- 有嵌入材料的标记物闪烁评分更高,提示材料存在影响闪烁显示。
- 表面粗糙度更高的标记物更易产生可操作闪烁,可用于目标定位。
关键影像表现/征象
- 闪烁评分从0分(确信无闪烁)到4分(确信 exuberant 闪烁),评分≥3分定义为可操作闪烁。
- 在尸体乳腺中,三种标记物(Cork、Professional Q、MRI [Flex])在两种或以上探头中表现出可操作闪烁。
- 有嵌入材料的标记物闪烁评分更高(固体凝胶体模OR=5.05,耦合剂OR=9.84)。
诊断标准与关键数值
- 可操作闪烁定义为闪烁评分≥3分,即足以仅依靠闪烁进行目标定位的置信度。
- 以C1-6探头为参考,9L探头在固体凝胶体模、耦合剂和尸体乳腺中的OR分别为0.36、0.83、0.04;ML6-15探头分别为0.07、0.18、0.00。
临床应用与阅片要点
- 在术前或术中定位标记淋巴结时,可优先选用C1-6或9L探头并注意观察闪烁伪像。
- 选择表面粗糙度较高的标记物可能更有利于利用闪烁伪像进行定位。
- 需注意ML6-15探头对闪烁伪像的显示能力较低,可能影响标记物识别。
局限性
- 研究为体外与离体实验,结果在活体乳腺中的适用性需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. Targeted axillary lymph node dissection after neoadjuvant systemic therapy (NST) for breast cancer depends on identifying marked metastatic lymph nodes. However, ultrasound visualization of biopsy markers is challenging. OBJECTIVE. The purpose of our study was to identify biopsy markers that show actionable twinkling in cadaveric breast and to assess the association of actionable twinkling with markers' surface roughness. METHODS. Commercial breast biopsy markers were evaluated for twinkling artifact in various experimental conditions relating to scanning medium (solid gel phantom, ultrasound coupling gel, cadaveric breast), transducer (ML6-15, 9L, C1-6), and embedding material (present vs absent). Markers were assigned twinkling scores from 0 (confident in no twinkling) to 4 (confident in exuberant twinkling); a score of 3 or greater represented actionable twinkling (sufficient confidence to rely solely on twinkling for target localization). Markers were hierarchically advanced to evaluation with increasingly complex media if showing at least minimal twinkling for a given medium. A 3D coherence optical profiler measured marker surface roughness. Mixed-effects proportional odds regression models assessed associations between twinkling scores and transducer and embedding material; Wilcoxon rank sum test evaluated associations between actionable twinkling and surface roughness. RESULTS. Thirty-five markers (21 with embedding material) were evaluated. Ten markers without embedding material advanced to evaluation in cadaveric breast. Higher twinkling scores were associated with presence of embedding material (odds ratio [OR] = 5.05 in solid gel phantom, 9.84 in coupling gel) and transducer (using the C1-6 transducer as reference; 9L transducer: OR = 0.36, 0.83, and 0.04 in solid gel phantom, ultrasound coupling gel, and cadaveric breast; ML6-15 transducer: OR = 0.07, 0.18, and 0.00 respectively; post hoc p between 9L and ML6-15: p < .001, p = .02, and p = .04). In cadaveric breast, three markers (Cork, Professional Q, MRI [Flex]) exhibited actionable twinkling for two or more transducers; surface roughness was significantly higher for markers with than without actionable twinkling for C1-6 (median values: 0.97 vs 0.35, p = .02) and 9L (1.75 vs 0.36; p = .002) transducers. CONCLUSION. Certain breast biopsy markers exhibited actionable twinkling in cadaveric breast. Twinkling was observed with greater confidence for the C1-6 and 9L transducers than the ML6-15 transducer. Actionable twinkling was associated with higher marker surface roughness. CLINICAL IMPACT. Use of twinkling for marker detection could impact preoperative or intraoperative localization after NST.
引用
- Lee, Larson, Urban, et al. Factors Associated With Ultrasound Color Doppler Twinkling by Breast Biopsy Markers: In Vitro and Ex Vivo Evaluation of 35 Commercially Available Markers. AJR Am J Roentgenol. 2022. PMID: 36043610. doi:10.2214/AJR.22.28107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。